India to Vietnam: Thalidomide Export Trade Route
India has recorded 9 verified shipments of Thalidomide exported to Vietnam, representing a combined trade value of $223.5K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $24.8K USD. The leading Indian exporter is UNITED BIOTECH PRIVATE LIMITED , which accounts for 71% of total export value with 4 shipments worth $159.7K USD. On the buying side, VIETNAM MEDICAL PRODUCTS IMPORT- is the largest importer in Vietnam with $159.7K USD in purchases. The top 3 suppliers — UNITED BIOTECH PRIVATE LIMITED , UNITED BIOTECH PRIVATE LIMITED, HEET HEALTHCARE PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Vietnam Thalidomide corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $223.5K USD. The route is dominated by UNITED BIOTECH PRIVATE LIMITED , which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's thalidomide manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $24.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 32.8%, placing it at rank #19 among India's top thalidomide export destinations globally.
On the import side, key buyers of Indian thalidomide in Vietnam include VIETNAM MEDICAL PRODUCTS IMPORT- , DELTA IMPORT EXPORT MEDICAL COMPANY, NGUYEN VAN VUONG. VIETNAM MEDICAL PRODUCTS IMPORT- is the single largest importer with 4 shipments valued at $159.7K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#19
- Annual growth+32.8%
- Demand growth+27.3%
- Regulatory ease66/100
Top 10 Indian Thalidomide Exporters to Vietnam
Showing top 10 of 3 Indian suppliers exporting Thalidomide to Vietnam, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNITED BIOTECH PRIVATE LIMITED Avg $39.9K per shipment | 4 | $159.7K | 71.4% |
| 2 | UNITED BIOTECH PRIVATE LIMITED Avg $15.6K per shipment | 4 | $62.5K | 27.9% |
| 3 | HEET HEALTHCARE PRIVATE LIMITED Avg $1.4K per shipment | 1 | $1.4K | 0.6% |
This table shows the top 10 of 3 Indian companies exporting thalidomide to Vietnam, ranked by total trade value. The listed exporters are: UNITED BIOTECH PRIVATE LIMITED , UNITED BIOTECH PRIVATE LIMITED, HEET HEALTHCARE PRIVATE LIMITED. UNITED BIOTECH PRIVATE LIMITED is the dominant supplier with 4 shipments worth $159.7K USD, giving it a 71% market share.
Top 10 Thalidomide Importers in Vietnam
Showing top 10 of 3 known buyers in Vietnam receiving Thalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian thalidomide in Vietnam include VIETNAM MEDICAL PRODUCTS IMPORT- , DELTA IMPORT EXPORT MEDICAL COMPANY, NGUYEN VAN VUONG. The largest importer is VIETNAM MEDICAL PRODUCTS IMPORT- , accounting for $159.7K USD across 4 shipments — representing 71% of all thalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VIETNAM MEDICAL PRODUCTS IMPORT- | 4 | $159.7K | 71.4% |
| 2 | DELTA IMPORT EXPORT MEDICAL COMPANY | 4 | $62.5K | 27.9% |
| 3 | NGUYEN VAN VUONG | 1 | $1.4K | 0.6% |
Top 10 Thalidomide Formulations Imported by Vietnam
Showing top 10 of 7 product formulations shipped on the India to Vietnam Thalidomide route, ranked by trade value
Vietnam imports a wide range of thalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — THALIDE 100 CAPSULE THALIDOMIDE CAPSULES — accounts for $97.3K USD across 2 shipments. A total of 7 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | THALIDE 100 CAPSULE THALIDOMIDE CAPSULES | 2 | $97.3K | 43.5% |
| 2 | THALIDE 50 CAPSULE THALIDOMIDE CAPSULES | 2 | $62.4K | 27.9% |
| 3 | THALIDE 100 CAPSULE ( THALIDOMIDE CAPSULES USP 100MG ) BATCH: TLCA5B1 MFG: 18/01/2025 EXP: 17/01/2027 | 1 | $23.1K | 10.3% |
| 4 | THALIDE 100 CAPSULE THALIDOMIDE CAPSULES USP 100MG BATCH TLCE5B2 MFG 05 25 EXP 05 27 | 1 | $20.5K | 9.2% |
| 5 | THALIDE 50 CAPSULE ( THALIDOMIDE CAPSULES USP 50MG ) BATCH: TLCA5A2 MFG: 29/01/2025 EXP:28/01/2027 | 1 | $11.8K | 5.3% |
| 6 | THALIDE 50 CAPSULE THALIDOMIDE CAPSULES USP 50MG BATCH TLCE5A3 MFG 05 25 EXP 05 27 | 1 | $7.1K | 3.2% |
| 7 | (PHARMA ITEM)THALIDOMIDE (100MG) - THALIDOMIDE (100MG) (OTHER DETAILS AS PER INV) | 1 | $1.4K | 0.6% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 6 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's thalidomide exports to Vietnam are driven primarily by a handful of large-scale manufacturers. UNITED BIOTECH PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Vietnam benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — UNITED BIOTECH PRIVATE LIMITED , UNITED BIOTECH PRIVATE LIMITED, HEET HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $24.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as thalide 50 capsule thalidomide capsules and thalide 100 capsule ( thalidomide capsules usp 100mg ) batch: tlca5b1 mfg: 18/01/2025 exp: 17/01/2027, suggesting that buyers in Vietnam tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VIETNAM MEDICAL PRODUCTS IMPORT- is the largest importer with 4 shipments worth $159.7K USD — representing 71% of all thalidomide imports from India on this route.
Route Statistics
- Trade Volume
- $223.5K
- Avg. Shipment
- $24.8K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~23 days
- Annual Growth
- +32.8%
Related Analysis
Other Thalidomide Routes
Unlock the Full India to Vietnam Thalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Vietnam Thalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Thalidomide to Vietnam?
The leading Indian exporters of Thalidomide to Vietnam are UNITED BIOTECH PRIVATE LIMITED , UNITED BIOTECH PRIVATE LIMITED, HEET HEALTHCARE PRIVATE LIMITED. UNITED BIOTECH PRIVATE LIMITED holds the largest market share at approximately 71% of total trade value on this route.
Q What is the total value of Thalidomide exports from India to Vietnam?
India exports Thalidomide to Vietnam worth approximately $223.5K USD across 9 recorded shipments. The average value per shipment is $24.8K USD.
Q Which ports does India use to ship Thalidomide to Vietnam?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 6 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Vietnam for Thalidomide?
The average transit time for Thalidomide shipments from India to Vietnam is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Vietnam Thalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.8% with demand growth tracking at 27.3%. The route is ranked #19 among India's top Thalidomide export destinations globally.
Q How many suppliers are active on the India to Vietnam Thalidomide route?
There are currently 3 active Indian suppliers exporting Thalidomide to Vietnam. The market is moderately concentrated with UNITED BIOTECH PRIVATE LIMITED accounting for 71% of total shipment value.
Q Who are the main importers of Thalidomide from India in Vietnam?
The leading importers of Indian Thalidomide in Vietnam include VIETNAM MEDICAL PRODUCTS IMPORT- , DELTA IMPORT EXPORT MEDICAL COMPANY, NGUYEN VAN VUONG. VIETNAM MEDICAL PRODUCTS IMPORT- is the largest buyer with 4 shipments worth $159.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Vietnam export trade corridor identified from Indian Customs (DGFT) records for Thalidomide.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Vietnam matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists